Jonathan Weyne

674 total citations
14 papers, 143 citations indexed

About

Jonathan Weyne is a scholar working on Immunology, Hematology and Genetics. According to data from OpenAlex, Jonathan Weyne has authored 14 papers receiving a total of 143 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Hematology and 4 papers in Genetics. Recurrent topics in Jonathan Weyne's work include Complement system in diseases (9 papers), Blood groups and transfusion (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Jonathan Weyne is often cited by papers focused on Complement system in diseases (9 papers), Blood groups and transfusion (6 papers) and Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers). Jonathan Weyne collaborates with scholars based in United States, South Korea and United Kingdom. Jonathan Weyne's co-authors include Lanny J. Rosenwasser, Terrence P. O’Brien, Umesh Chaudhari, Haixin Zhang, Jessica J. Jalbert, Jamile M. Shammo, Lori Morton, Olivier Harari, Ni Yan and A. J. Rankin and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Investigative Ophthalmology & Visual Science.

In The Last Decade

Jonathan Weyne

13 papers receiving 138 citations

Peers

Jonathan Weyne
Katherine A. Vernon United Kingdom
Rachel Challis United Kingdom
Emilia Arjona Spain
Kathryn J. Kitzmiller United States
Andrés Brodsky Argentina
Sylvie Grandemange France
Rebecca Schleicher Germany
A. Parissiadis France
Francesca Bertinetto Italy
Sindhuri Prakash United States
Katherine A. Vernon United Kingdom
Jonathan Weyne
Citations per year, relative to Jonathan Weyne Jonathan Weyne (= 1×) peers Katherine A. Vernon

Countries citing papers authored by Jonathan Weyne

Since Specialization
Citations

This map shows the geographic impact of Jonathan Weyne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Weyne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Weyne more than expected).

Fields of papers citing papers by Jonathan Weyne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Weyne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Weyne. The network helps show where Jonathan Weyne may publish in the future.

Co-authorship network of co-authors of Jonathan Weyne

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Weyne. A scholar is included among the top collaborators of Jonathan Weyne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Weyne. Jonathan Weyne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
2.
Jang, Jun‐Ho, Raymond Wong, Jonathan Weyne, et al.. (2023). P775: LONG-TERM EFFICACY AND SAFETY OF POZELIMAB MONOTHERAPY IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA. HemaSphere. 7(S3). e4357016–e4357016. 2 indexed citations
3.
Jang, Jun Ho, Raymond Wong, Jonathan Weyne, et al.. (2022). Long-Term Efficacy and Safety of Pozelimab Monotherapy in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 140(Supplement 1). 5309–5310. 2 indexed citations
4.
Ailawadhi, Sikander, Qiufei Ma, Jessica J. Jalbert, et al.. (2022). Prevalence of ocular comorbidities in patients with multiple myeloma: An analysis of U.S. claims data.. Journal of Clinical Oncology. 40(16_suppl). 8038–8038. 2 indexed citations
5.
Jang, Jun Ho, Raymond Wong, Bradley Dain, et al.. (2022). A Phase 2, Randomized Trial Evaluating the Safety and Efficacy of Pozelimab and Cemdisiran in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 140(Supplement 1). 8172–8173.
6.
Gelfman, Sahar, Dominique Monnet, Ann J. Ligocki, et al.. (2021). ERAP1, ERAP2, and Two Copies of HLA-Aw19 Alleles Increase the Risk for Birdshot Chorioretinopathy in HLA-A29 Carriers. Investigative Ophthalmology & Visual Science. 62(14). 3–3. 9 indexed citations
7.
Jang, Jun‐Ho, Jonathan Weyne, Umesh Chaudhari, et al.. (2021). Pozelimab, a Human Monoclonal Antibody Against Complement Factor C5, Provided Inhibition of Intravascular Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria. Blood. 138(Supplement 1). 1128–1128. 6 indexed citations
8.
9.
Weyne, Jonathan, Andrew Blauvelt, Marjolein de Bruin‐Weller, et al.. (2020). Patient-Reported Ocular Disorders and Symptoms in Adults with Moderate-to-Severe Atopic Dermatitis: Screening and Baseline Survey Data from a Clinical Trial. Dermatology and Therapy. 10(6). 1415–1421. 6 indexed citations
10.
Jalbert, Jessica J., Umesh Chaudhari, Haixin Zhang, Jonathan Weyne, & Jamile M. Shammo. (2019). Epidemiology of PNH and Real-World Treatment Patterns Following an Incident PNH Diagnosis in the US. Blood. 134(Supplement_1). 3407–3407. 38 indexed citations
11.
Devalaraja‐Narashimha, Kishor, Ni Yan, Cong Huang, et al.. (2019). Pozelimab, a Human Antibody Against Complement Factor C5, Demonstrates Robust Inhibition of Alternative Complement Activity Both in Normal Human Serum and in Phase I Normal Healthy Volunteers. Blood. 134(Supplement_1). 2278–2278. 7 indexed citations
12.
13.
Rosenwasser, Lanny J., Terrence P. O’Brien, & Jonathan Weyne. (2005). Mast cell stabilization and anti-histamine effects of olopatadine ophthalmic solution: a review of pre-clinical and clinical research. Current Medical Research and Opinion. 21(9). 1377–1387. 36 indexed citations
14.
Weyne, Jonathan. (2002). INTRAOCULAR LENSES IN CATARACT AND REFRACTIVE SURGERY. Ophthalmic surgery, lasers & imaging retina. 33(4). 352–352. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katherine A. Vernon Breakdown of academic impact, for papers by Rachel Challis Breakdown of academic impact, for papers by Emilia Arjona Breakdown of academic impact, for papers by Kathryn J. Kitzmiller Breakdown of academic impact, for papers by Andrés Brodsky Breakdown of academic impact, for papers by Sylvie Grandemange Breakdown of academic impact, for papers by Rebecca Schleicher Breakdown of academic impact, for papers by A. Parissiadis Breakdown of academic impact, for papers by Francesca Bertinetto Breakdown of academic impact, for papers by Sindhuri Prakash
Rankless by CCL
2026